Narrative review / 2013
Fasting therapy and intermittent fasting show potential benefits for chronic inflammatory and degenerative diseases in clinical and experimental evidence.
This review evaluates the evidence surrounding deliberate and medically supervised modified fasting (200-500 kcal/day for 7-21 days) for disease prevention and treatment. Observational and empirical evidence suggests efficacy in rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome, with randomized controlled trials confirming benefits of fasting followed by a vegetarian diet in rheumatoid arthritis. Additionally, intermittent fasting is associated with deceleration or prevention of chronic degenerative diseases and may serve as an adjunct to cancer chemotherapy.
- Study type
- Narrative review
- Who was studied
- Patients with various chronic diseases and general populations
- What was measured
- Treatment and prevention of chronic diseases, including rheumatic diseases, hypertension, and metabolic syndrome
THE PAPER
Fasting therapy for treating and preventing disease - current state of evidence.
Michalsen A, Li C. Forsch Komplementmed, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.